Breaking
Thursday, July 9, 2026

News

🇺🇸 FDA Page 67

Latest pharmaceutical news, drug approvals, and FDA regulatory updates

Showing 793–804 of 807 articles

High impact NewsApr 2, 2026

FDA Approves Elarek: New Option for Osteoporosis Prevention

FDA · Osteoporosis · 6 min

Dr. Sarah Mitchell
High impact NewsApr 1, 2026

FDA Approves First Interchangeable Biosimilar for Stelara (Ustekinumab)

FDA · autoimmune diseases · 5 min

Dr. Sarah Mitchell
Critical impact NewsMar 31, 2026

FDA Approves Novel Anti-Inflammatory Drug for Atopic Dermatitis Treatment

FDA · Dermatology · 4 min

Dr. Sarah Mitchell
High impact NewsMar 31, 2026

FDA Approves Amgen's Bispecific Antibody for Metastatic Colorectal Cancer

FDA · Oncology · 4 min

Dr. Sarah Mitchell
Critical impact NewsMar 31, 2026

FDA Approves Syfovre: First Treatment for Geographic Atrophy

FDA · Ophthalmology · 4 min

Dr. Sarah Mitchell
High impact NewsMar 31, 2026

FDA Approves EndeavorRx: First Digital Therapeutic for Adult ADHD

FDA · Neurology · 4 min

Dr. Sarah Mitchell
Critical impact NewsMar 31, 2026

FDA Approves Roche's NTRK Fusion Therapy for Solid Tumors

FDA · Oncology · 3 min

Dr. Sarah Mitchell
High impact NewsMar 31, 2026

FDA Approves First CRISPR Gene Therapy for Sickle Cell Disease

FDA · Hematology · 4 min

Dr. Sarah Mitchell
Critical impact NewsMar 31, 2026

FDA Approves First Interchangeable Humira Biosimilar: Key Details

FDA · Immunology · 5 min

Dr. Sarah Mitchell
Critical impact NewsMar 31, 2026

FDA Approves Gilead's Long-Acting HIV Treatment for Bi-Monthly Dosing

FDA · HIV/AIDS · 4 min

Dr. Sarah Mitchell
Critical impact NewsMar 31, 2026

FDA Grants Priority Review to AstraZeneca's Wilson Disease Treatment

FDA · Rare Diseases · 4 min

Dr. Sarah Mitchell
Critical impact NewsMar 31, 2026

FDA Grants Accelerated Approval to Eli Lilly's Donanemab for Alzheimer's

FDA · Neurology · 5 min

Dr. Sarah Mitchell